Back to Journals » International Journal of Nanomedicine » Volume 8 » Issue 1

Nanolipodendrosome-loaded glatiramer acetate and myogenic differentiation 1 as augmentation therapeutic strategy approaches in muscular dystrophy

Authors Afzal E, Zakeri S, Keyhanvar P, Bagheri M, Mahjoubi P, Asadian M, Omoomi N, Dehqanian M, Ghalandarlaki N, Darvishmohammadi T, Farjadian F, Golvajoee MS, Afzal S, Ghaffari M, Cohan RA, Gravand A, Ardestani MS

Received 25 January 2013

Accepted for publication 31 March 2013

Published 8 August 2013 Volume 2013:8(1) Pages 2943—2960

DOI https://doi.org/10.2147/IJN.S43219

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 3

Ehsan Afzal,1 Saba Zakeri,1 Peyman Keyhanvar,2 Meisam Bagheri,3,4 Parvin Mahjoubi,5 Mahtab Asadian,5 Nogol Omoomi,5 Mohammad Dehqanian,6 Negar Ghalandarlaki,1 Tahmineh Darvishmohammadi,1 Fatemeh Farjadian,7 Mohammad Sadegh Golvajoee,1 Shadi Afzal,8 Maryam Ghaffari,9 Reza Ahangari Cohan,10 Amin Gravand,11 Mehdi Shafiee Ardestani12,13

1Department of Biology, Science and Research Branch, Islamic Azad University, 2School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran; 3Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore, India; 4Autoimmune Disease Research Center, Shiraz University of Medical Sciences, Shiraz, 5National Cell Bank, Pasteur Institute of Iran, 6Department of Nanotechnology, Faculty of Advanced Sciences and Technologies, Pharmaceutical Sciences Branch, Islamic Azad University, Tehran, 7Department of Chemistry, College of Science, Shiraz University, Shiraz, 8Department of English, Beyza Branch, Islamic Azad University, Beyza, 9Department of Basic Science at Apadana Education Institute, Shiraz, 10Department of Virology, Pasteur Institute of Iran, Tehran, 11Faculty of Pharmacy, Ahwaz Jondishapour University of Medical Sciences, Ahwaz, 12Department of Medicinal Chemistry and Radiopharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, 13Department of Radiopharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran

Backgrond: Muscular dystrophies consist of a number of juvenile and adult forms of complex disorders which generally cause weakness or efficiency defects affecting skeletal muscles or, in some kinds, other types of tissues in all parts of the body are vastly affected. In previous studies, it was observed that along with muscular dystrophy, immune inflammation was caused by inflammatory cells invasion – like T lymphocyte markers (CD8+/CD4+). Inflammatory processes play a major part in muscular fibrosis in muscular dystrophy patients. Additionally, a significant decrease in amounts of two myogenic recovery factors (myogenic differentation 1 [MyoD] and myogenin) in animal models was observed. The drug glatiramer acetate causes anti-inflammatory cytokines to increase and T helper (Th) cells to induce, in an as yet unknown mechanism. MyoD recovery activity in muscular cells justifies using it alongside this drug.
Methods: In this study, a nanolipodendrosome carrier as a drug delivery system was designed. The purpose of the system was to maximize the delivery and efficiency of the two drug factors, MyoD and myogenin, and introduce them as novel therapeutic agents in muscular dystrophy phenotypic mice. The generation of new muscular cells was analyzed in SW1 mice. Then, immune system changes and probable side effects after injecting the nanodrug formulations were investigated.
Results: The loaded lipodendrimer nanocarrier with the candidate drug, in comparison with the nandrolone control drug, caused a significant increase in muscular mass, a reduction in CD4+/CD8+ inflammation markers, and no significant toxicity was observed. The results support the hypothesis that the nanolipodendrimer containing the two candidate drugs will probably be an efficient means to ameliorate muscular degeneration, and warrants further investigation.

Keywords: muscular dystrophy, glatiramer acetate, MyoD factor, drug delivery

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Other articles by this author:

Novel chlorambucil-conjugated anionic linear-globular PEG-based second-generation dendrimer: in vitro/in vivo improved anticancer activity

Assadi A, Najafabadi VS, Shandiz SAS, Boroujeni AS, Ashrafi S, Vaziri AZ, Ghoreishi SM, Aghasadeghi MR, Ebrahimi SES, Pirali-Hamedani M, Ardestani MS

OncoTargets and Therapy 2016, 9:5531-5543

Published Date: 7 September 2016

Phytosynthesis of silver nanoparticles using Artemisia marschalliana Sprengel aerial part extract and assessment of their antioxidant, anticancer, and antibacterial properties

Salehi S, Shandiz SAS, Ghanbar F, Darvish MR, Ardestani MS, Mirzaie A, Jafari M

International Journal of Nanomedicine 2016, 11:1835-1846

Published Date: 29 April 2016

Gd3+-DTPA-DG: novel nanosized dual anticancer and molecular imaging agent

Amanlou M, Siadat SD, Ebrahimi SES, Alavi A, Aghasadeghi MR, Ardestani MS, Shanehsaz S, Ghorbani M, Mehravi B, Alavidjeh MS, Jabbari-Arabzadeh A, Abbasi M

International Journal of Nanomedicine 2011, 6:747-763

Published Date: 11 April 2011

Readers of this article also read:

Zerumbone-loaded nanostructured lipid carrier induces G2/M cell cycle arrest and apoptosis via mitochondrial pathway in a human lymphoblastic leukemia cell line

Rahman HS, Rasedee A, Abdul AB, Zeenathul NA, Othman HH, Yeap SK, How CW, Wan Nor Hafiza WAG

International Journal of Nanomedicine 2014, 9:527-538

Published Date: 16 January 2014

Polymeric nanoparticles enhance the sonodynamic activity of meso-tetrakis (4-sulfonatophenyl) porphyrin in an in vitro neuroblastoma model

Canaparo R, Varchi G, Ballestri M, Foglietta F, Sotgiu G, Guerrini A, Francovich A, Civera P, Frairia R, Serpe L

International Journal of Nanomedicine 2013, 8:4247-4263

Published Date: 6 November 2013

The impact of PEGylation patterns on the in vivo biodistribution of mixed shell micelles

Gao H, Liu J, Yang C, Cheng T, Chu L, Xu H, Meng A, Fan S, Shi L, Liu J

International Journal of Nanomedicine 2013, 8:4229-4246

Published Date: 5 November 2013

Silver nanoparticle/chitosan oligosaccharide/poly(vinyl alcohol) nanofibers as wound dressings: a preclinical study

Li CW, Fu RQ, Yu CP, Li ZH, Guan HY, Hu DQ, Zhao DH, Lu LC

International Journal of Nanomedicine 2013, 8:4131-4145

Published Date: 1 November 2013

Selective laser sintering fabrication of nano-hydroxyapatite/poly-ε-caprolactone scaffolds for bone tissue engineering applications

Xia Y, Zhou PY, Cheng XS, Xie Y, Liang C, Li C, Xu SG

International Journal of Nanomedicine 2013, 8:4197-4213

Published Date: 1 November 2013

Microwave-assisted synthesis of SnO2 nanorods for oxygen gas sensing at room temperature

Azam A, Habib SS, Salah NA, Ahmed F

International Journal of Nanomedicine 2013, 8:3875-3882

Published Date: 9 October 2013

Bioengineering in the oral cavity: our experience

Catalfamo L, Belli E, Nava C, Mici E, Calvo A, D'Alessandro B, De Ponte FS

International Journal of Nanomedicine 2013, 8:3883-3886

Published Date: 9 October 2013

Barium titanate core – gold shell nanoparticles for hyperthermia treatments

FarrokhTakin E, Ciofani G, Puleo GL, de Vito G, Filippeschi C, Mazzolai B, Piazza V, Mattoli V

International Journal of Nanomedicine 2013, 8:2319-2331

Published Date: 28 June 2013

Enhanced in vivo osteogenesis by nanocarrier-fused bone morphogenetic protein-4

Shiozaki Y, Kitajima T, Mazaki T, Yoshida A, Tanaka M, Umezawa A, Nakamura M, Yoshida Y, Ito Y, Ozaki T, Matsukawa A

International Journal of Nanomedicine 2013, 8:1349-1360

Published Date: 9 April 2013

Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells

Kanmogne GD, Singh S, Roy U, Liu X, McMillan J, Gorantla S, Balkundi S, Smith N, Alnouti Y, Gautam N, Zhou Y, Poluektova L, Kabanov A, Bronich T, Gendelman HE

International Journal of Nanomedicine 2012, 7:2373-2388

Published Date: 8 May 2012